Navigation Links
HUYA Bioscience Int'l Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
Date:6/17/2008

the development process."

HUYA's innovative co-development model

HUYA was one of the first companies to recognize China's potential to help meet the global need for untapped sources of pre-clinical and clinical stage compounds for the drug development process. Leveraging the HUYA Integrated Co-development Model for partnering with Chinese research institutions and pharmaceutical companies, HUYA identifies and licenses the most promising pre-clinical and clinical stage compounds in China. Through collaborations with its Chinese partners, the company provides a bridge into the Western development process and biopharma market.

Compounds are validated through a rigorous discovery, selection and development process in China, streamlining and accelerating development in the West, while confirming a compound's safety profile. HUYA's model relies on longevity of relationships with its Chinese partners to provide a continuous source of compounds rather than a one-time single compound strategy.

One of the key differentiators of HUYA's approach is the assembly of a high-level team of scientific and clinical advisors for each new compound. The team collaborates with its Chinese partners to discuss and design clinical trials as the compounds enter the U.S. development process, speeding the process and mitigating risk. HUYA's global team of scientists and clinicians includes Benedict Lucchesi, Ph.D. MD, Peter R. Kowey, M.D., Dennis Roy, M.D., Jefferson L. Anderson, M.D., Eric J. Topol, M.D., and Stanley Nattel, M.D.

About HUYA

HUYA is the leader in U.S./China pharmaceutical co-development. With three strategic offices in China, the broadest Chinese compound portfolio, and more exclusive agreements with premier Chinese biotech centers than any other company, HUYA has pioneered the most innovative and productive approach for pharmaceutical co-development between the U.S. and China. HUYA has joint headquarters offices in San Diego, CA, and S
'/>"/>

SOURCE HUYA Bioscience International
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Neurocrine Biosciences Completes Petal Study Treatment Phase for Endometriosis
2. Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
3. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
4. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
5. Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743
6. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
7. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
8. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
9. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
10. Neurocrine Biosciences Reports First Quarter 2008 Results
11. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...CAMBRIDGE, Mass., Nov. 19 Ligon Di...le microarray technology to find drugs against hig...d $1M in seed financing led by incTANK Ventures. T...itial discovery campaign that will screen over 100...estment, incTANK Ventures General Partner Christia...
(Date:11/19/2009)... Part of International Internet Week of Action ,...swire/ -- The U.S. Food and Drug Administration to...al effort, called the International Internet Week ... involving medical products. ,, (Logo: http://..., During the effort, the FDA,s Office of Crimina...
(Date:11/19/2009)...WPORT NEWS, Va., Nov. 19 Breast-Sp...I/MBI) has been recognized and endorsed by two hig...reast cancer: The Society of Breast Imaging (SBI) ...es published articles supporting the further appli... the early detection of breast cancer. ,, "Thes...
Breaking Medicine Technology:Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 3Custom Spine Receives 510k Clearance of Regent ACP 6014 1Custom Spine Receives 510k Clearance of Regent ACP 6014 2Bayer Consumer Care Launches Citracal 28R 29 Calcium Plus Heart Health First Ever Leading Calcium Supplement to Help Support Bone AND Heart Health 6011 1Bayer Consumer Care Launches Citracal 28R 29 Calcium Plus Heart Health First Ever Leading Calcium Supplement to Help Support Bone AND Heart Health 6011 2Bayer Consumer Care Launches Citracal 28R 29 Calcium Plus Heart Health First Ever Leading Calcium Supplement to Help Support Bone AND Heart Health 6011 3Competitive Technologies Selects RF 7CBinder as Public Relations Agency of Record 6008 1Competitive Technologies Selects RF 7CBinder as Public Relations Agency of Record 6008 2Competitive Technologies Selects RF 7CBinder as Public Relations Agency of Record 6008 3
...land, January 26 Debiopharm Group,(Debiopharm), a...hat focuses,on serious medical conditions and part...on of its first patient in a phase IIb clinical st...inhibitor with a potent anti-hepatitis C,(HCV) eff...trolled,parallel-group study will investigate the ...
...2nd Generation Oxazolidinone Enrolls in Four Month...c. today announced the completion of enrollment in...al testing the oral dosage form of torezolid (also...n and skin structure infections (cSSSI). The tria... United States, examined the efficacy and safety o...
Other Medicine Technology:Clinical Update - Debio 025 in Hepatitis C 2Clinical Update - Debio 025 in Hepatitis C 3Trius Completes Enrollment in Phase 2 Clinical Trial Evaluating Torezolid (TR-701) in Patients With Complicated Skin and Skin Structure Infections 2
(Date:11/21/2009)... A regional initiative l...river blindness) in the Americas has substantially...ears, as evidenced by a 31% decrease in the number... in six endemic countries. Results were reported ...ociety of Tropical Medicine and Hygiene (ASTMH). ...
(Date:11/21/2009)..., 2009 Test Test Test Te...st Test Test Test Test Test,Test Test Test Test Te...st,Test Test Test Test Test Test Test Test Test Te...est More test More test More test More test,More t...est More test More,test More test , , Please i...
(Date:11/21/2009)...ive medical apparel company launches men,s lab coa... San Clemente, Calif. (PRWEB) November 21, 20... apparel, today announced the launch of its men,s ...leading international trade fair for the medical i...gurates its men,s collection with three varying la...
(Date:11/21/2009)... Hall, president and chief executive officer of th...he following statement regarding the inclusion of ...annual wellness for Medicare beneficiaries in &quo...uot; that was introduced last night: , ...09 -- Eric J. Hall, president and chief executive ...
(Date:11/21/2009)... Group ask whether there is a secret to ,alcohol r... London, UK (PRWEB) November 21, 200...hree of the adult UK population drinking enough al...ed liver disease*, it is hardly a surprise that ma...rammes and residential centres for help. However, ...
Breaking Medicine News(10 mins):Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4
... the animals have lost the ability to replace thei... the ability of replacing the missing //leg with a...ow research teams of Salk Institute for Biological...ial for such regeneration may also exists innately...
...men boxers gathered here for the ongoing World Cha...the fact that they stand a chance //of rupturing t...ceiving. While some are simply after medals,...ird successive gold medal in the 46 kg at the Worl...
...reak of Norovirus has been reported in Royal Bourn...n the complete closure of wards 4,5,27 // and 28 t...at the virus has been contained in the ward areas....t patients in the hospital as a precautionary meas...
...ades, researchers have suspected a connection betw... (RA). Previous research has yielded widely varyin...// , partly because studies have used different di...al Meeting on Nov. 11 confirming that patients wit...
... researchers have produced a vaccine that activate... to attack cancerous cells. // During a clin...ersity of Nottingham discovered that when the vacc...r 15 issue of Clinical Cancer Research has carried...
...rious post-operative eye ailment that swept along ...aract-surgery unit in Scarborough Hospital, one of... The Hospital, which performs around 5,000 eye ... toxic anterior segment syndrome, or TASS. Moreov...
Other Medicine News:Health News:Limb Regeneration Exists Innately In All Vertebrates – Says Researc 2Health News:Limb Regeneration Exists Innately In All Vertebrates – Says Researc 3Health News:As these women box on, do they risk becoming mothers? 2Health News:As these women box on, do they risk becoming mothers? 3Health News:Study Examines Link Between Rheumatoid Arthritis and Chronic Lung Diseases 2Health News:A novel vaccine proves a shot in the arm for colorectal cancer patients 2Health News:Eye Surgeries Remain Cancelled Due To TASS Outbreak In Toronto 2
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
Medicine Products: